Financial RatingsThe analyst reiterates an Outperform rating and target price of $12, reflecting confidence in the company's prospects.
Revenue GrowthU.S. Revenue of $132 million was up ~13% quarter over quarter, delivering the strongest Q4 in PHX's history.
Shareholder ReturnsThe company plans to return ~70% of excess free cash flow to shareholders, which represents one of the highest levels in the coverage group.